Both histamine H2-receptor antagonists and gastric proton pump inhibitors are now world-widely used as the first choice for the treatment of acid-related diseases.

The global Gastric Antisecretory Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Gastric Antisecretory Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Gastric Antisecretory Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Gastric Antisecretory Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastric Antisecretory Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Gastric Antisecretory Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Gastric Antisecretory Drug sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Gastric Antisecretory Drug Market Report

Report Metric	Details
Report Name	Gastric Antisecretory Drug Market
CAGR	5%
Segment by Type	H2-receptor Antagonists Gastric Proton Pump Inhibitors Others
Segment by Application	Dyspepsia Peptic Ulcer Gastroesophageal Reflux Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda, NCPC, Luoxin
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Gastric Antisecretory Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Gastric Antisecretory Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastric Antisecretory Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastric Antisecretory Drug Market report?

Ans: The main players in the Gastric Antisecretory Drug Market are AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda, NCPC, Luoxin

What are the Application segmentation covered in the Gastric Antisecretory Drug Market report?

Ans: The Applications covered in the Gastric Antisecretory Drug Market report are Dyspepsia, Peptic Ulcer, Gastroesophageal Reflux, Others

What are the Type segmentation covered in the Gastric Antisecretory Drug Market report?

Ans: The Types covered in the Gastric Antisecretory Drug Market report are H2-receptor Antagonists, Gastric Proton Pump Inhibitors, Others

1 Study Coverage

1.1 Gastric Antisecretory Drug Product Introduction

1.2 Market by Type

1.2.1 Global Gastric Antisecretory Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 H2-receptor Antagonists

1.2.3 Gastric Proton Pump Inhibitors

1.2.4 Others

1.3 Market by Application

1.3.1 Global Gastric Antisecretory Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Dyspepsia

1.3.3 Peptic Ulcer

1.3.4 Gastroesophageal Reflux

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Gastric Antisecretory Drug Sales Estimates and Forecasts 2019-2030

2.2 Global Gastric Antisecretory Drug Revenue by Region

2.2.1 Global Gastric Antisecretory Drug Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Gastric Antisecretory Drug Revenue by Region (2019-2024)

2.2.3 Global Gastric Antisecretory Drug Revenue by Region (2025-2030)

2.2.4 Global Gastric Antisecretory Drug Revenue Market Share by Region (2019-2030)

2.3 Global Gastric Antisecretory Drug Sales Estimates and Forecasts 2019-2030

2.4 Global Gastric Antisecretory Drug Sales by Region

2.4.1 Global Gastric Antisecretory Drug Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Gastric Antisecretory Drug Sales by Region (2019-2024)

2.4.3 Global Gastric Antisecretory Drug Sales by Region (2025-2030)

2.4.4 Global Gastric Antisecretory Drug Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Gastric Antisecretory Drug Sales by Manufacturers

3.1.1 Global Gastric Antisecretory Drug Sales by Manufacturers (2019-2024)

3.1.2 Global Gastric Antisecretory Drug Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastric Antisecretory Drug in 2023

3.2 Global Gastric Antisecretory Drug Revenue by Manufacturers

3.2.1 Global Gastric Antisecretory Drug Revenue by Manufacturers (2019-2024)

3.2.2 Global Gastric Antisecretory Drug Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Gastric Antisecretory Drug Revenue in 2023

3.3 Global Key Players of Gastric Antisecretory Drug, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Gastric Antisecretory Drug Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Gastric Antisecretory Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Gastric Antisecretory Drug, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Gastric Antisecretory Drug, Product Offered and Application

3.8 Global Key Manufacturers of Gastric Antisecretory Drug, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Gastric Antisecretory Drug Sales by Type

4.1.1 Global Gastric Antisecretory Drug Historical Sales by Type (2019-2024)

4.1.2 Global Gastric Antisecretory Drug Forecasted Sales by Type (2025-2030)

4.1.3 Global Gastric Antisecretory Drug Sales Market Share by Type (2019-2030)

4.2 Global Gastric Antisecretory Drug Revenue by Type

4.2.1 Global Gastric Antisecretory Drug Historical Revenue by Type (2019-2024)

4.2.2 Global Gastric Antisecretory Drug Forecasted Revenue by Type (2025-2030)

4.2.3 Global Gastric Antisecretory Drug Revenue Market Share by Type (2019-2030)

4.3 Global Gastric Antisecretory Drug Price by Type

4.3.1 Global Gastric Antisecretory Drug Price by Type (2019-2024)

4.3.2 Global Gastric Antisecretory Drug Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Gastric Antisecretory Drug Sales by Application

5.1.1 Global Gastric Antisecretory Drug Historical Sales by Application (2019-2024)

5.1.2 Global Gastric Antisecretory Drug Forecasted Sales by Application (2025-2030)

5.1.3 Global Gastric Antisecretory Drug Sales Market Share by Application (2019-2030)

5.2 Global Gastric Antisecretory Drug Revenue by Application

5.2.1 Global Gastric Antisecretory Drug Historical Revenue by Application (2019-2024)

5.2.2 Global Gastric Antisecretory Drug Forecasted Revenue by Application (2025-2030)

5.2.3 Global Gastric Antisecretory Drug Revenue Market Share by Application (2019-2030)

5.3 Global Gastric Antisecretory Drug Price by Application

5.3.1 Global Gastric Antisecretory Drug Price by Application (2019-2024)

5.3.2 Global Gastric Antisecretory Drug Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Gastric Antisecretory Drug Market Size by Type

6.1.1 US & Canada Gastric Antisecretory Drug Sales by Type (2019-2030)

6.1.2 US & Canada Gastric Antisecretory Drug Revenue by Type (2019-2030)

6.2 US & Canada Gastric Antisecretory Drug Market Size by Application

6.2.1 US & Canada Gastric Antisecretory Drug Sales by Application (2019-2030)

6.2.2 US & Canada Gastric Antisecretory Drug Revenue by Application (2019-2030)

6.3 US & Canada Gastric Antisecretory Drug Market Size by Country

6.3.1 US & Canada Gastric Antisecretory Drug Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Gastric Antisecretory Drug Sales by Country (2019-2030)

6.3.3 US & Canada Gastric Antisecretory Drug Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Gastric Antisecretory Drug Market Size by Type

7.1.1 Europe Gastric Antisecretory Drug Sales by Type (2019-2030)

7.1.2 Europe Gastric Antisecretory Drug Revenue by Type (2019-2030)

7.2 Europe Gastric Antisecretory Drug Market Size by Application

7.2.1 Europe Gastric Antisecretory Drug Sales by Application (2019-2030)

7.2.2 Europe Gastric Antisecretory Drug Revenue by Application (2019-2030)

7.3 Europe Gastric Antisecretory Drug Market Size by Country

7.3.1 Europe Gastric Antisecretory Drug Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Gastric Antisecretory Drug Sales by Country (2019-2030)

7.3.3 Europe Gastric Antisecretory Drug Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Gastric Antisecretory Drug Market Size

8.1.1 China Gastric Antisecretory Drug Sales (2019-2030)

8.1.2 China Gastric Antisecretory Drug Revenue (2019-2030)

8.2 China Gastric Antisecretory Drug Market Size by Application

8.2.1 China Gastric Antisecretory Drug Sales by Application (2019-2030)

8.2.2 China Gastric Antisecretory Drug Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Gastric Antisecretory Drug Market Size by Type

9.1.1 Asia Gastric Antisecretory Drug Sales by Type (2019-2030)

9.1.2 Asia Gastric Antisecretory Drug Revenue by Type (2019-2030)

9.2 Asia Gastric Antisecretory Drug Market Size by Application

9.2.1 Asia Gastric Antisecretory Drug Sales by Application (2019-2030)

9.2.2 Asia Gastric Antisecretory Drug Revenue by Application (2019-2030)

9.3 Asia Gastric Antisecretory Drug Sales by Region

9.3.1 Asia Gastric Antisecretory Drug Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Gastric Antisecretory Drug Revenue by Region (2019-2030)

9.3.3 Asia Gastric Antisecretory Drug Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Gastric Antisecretory Drug Market Size by Type

10.1.1 Middle East, Africa and Latin America Gastric Antisecretory Drug Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Gastric Antisecretory Drug Market Size by Application

10.2.1 Middle East, Africa and Latin America Gastric Antisecretory Drug Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Gastric Antisecretory Drug Sales by Country

10.3.1 Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Gastric Antisecretory Drug Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Bayer

11.1.1 Bayer Company Information

11.1.2 Bayer Overview

11.1.3 Bayer Gastric Antisecretory Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Bayer Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Bayer Recent Developments

11.2 Cadila Pharmaceuticals

11.2.1 Cadila Pharmaceuticals Company Information

11.2.2 Cadila Pharmaceuticals Overview

11.2.3 Cadila Pharmaceuticals Gastric Antisecretory Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Cadila Pharmaceuticals Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Cadila Pharmaceuticals Recent Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Information

11.3.2 AstraZeneca Overview

11.3.3 AstraZeneca Gastric Antisecretory Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 AstraZeneca Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 AstraZeneca Recent Developments

11.4 Jiangsu Aosaikang

11.4.1 Jiangsu Aosaikang Company Information

11.4.2 Jiangsu Aosaikang Overview

11.4.3 Jiangsu Aosaikang Gastric Antisecretory Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Jiangsu Aosaikang Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Jiangsu Aosaikang Recent Developments

11.5 Eisai

11.5.1 Eisai Company Information

11.5.2 Eisai Overview

11.5.3 Eisai Gastric Antisecretory Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Eisai Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Eisai Recent Developments

11.6 Pfizer

11.6.1 Pfizer Company Information

11.6.2 Pfizer Overview

11.6.3 Pfizer Gastric Antisecretory Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Pfizer Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Pfizer Recent Developments

11.7 Altana Pharma

11.7.1 Altana Pharma Company Information

11.7.2 Altana Pharma Overview

11.7.3 Altana Pharma Gastric Antisecretory Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Altana Pharma Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Altana Pharma Recent Developments

11.8 Takeda

11.8.1 Takeda Company Information

11.8.2 Takeda Overview

11.8.3 Takeda Gastric Antisecretory Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Takeda Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Takeda Recent Developments

11.9 NCPC

11.9.1 NCPC Company Information

11.9.2 NCPC Overview

11.9.3 NCPC Gastric Antisecretory Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 NCPC Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 NCPC Recent Developments

11.10 Luoxin

11.10.1 Luoxin Company Information

11.10.2 Luoxin Overview

11.10.3 Luoxin Gastric Antisecretory Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Luoxin Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Luoxin Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Gastric Antisecretory Drug Industry Chain Analysis

12.2 Gastric Antisecretory Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Gastric Antisecretory Drug Production Mode & Process

12.4 Gastric Antisecretory Drug Sales and Marketing

12.4.1 Gastric Antisecretory Drug Sales Channels

12.4.2 Gastric Antisecretory Drug Distributors

12.5 Gastric Antisecretory Drug Customers

13 Market Dynamics

13.1 Gastric Antisecretory Drug Industry Trends

13.2 Gastric Antisecretory Drug Market Drivers

13.3 Gastric Antisecretory Drug Market Challenges

13.4 Gastric Antisecretory Drug Market Restraints

14 Key Findings in The Global Gastric Antisecretory Drug Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Bayer

Cadila Pharmaceuticals

List of Tables

Table 1. Global Gastric Antisecretory Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of H2-receptor Antagonists

Table 3. Major Manufacturers of Gastric Proton Pump Inhibitors

Table 4. Major Manufacturers of Others

Table 5. Global Gastric Antisecretory Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Gastric Antisecretory Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Gastric Antisecretory Drug Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Gastric Antisecretory Drug Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Gastric Antisecretory Drug Revenue Market Share by Region (2019-2024)

Table 10. Global Gastric Antisecretory Drug Revenue Market Share by Region (2025-2030)

Table 11. Global Gastric Antisecretory Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Gastric Antisecretory Drug Sales by Region (2019-2024) & (K Units)

Table 13. Global Gastric Antisecretory Drug Sales by Region (2025-2030) & (K Units)

Table 14. Global Gastric Antisecretory Drug Sales Market Share by Region (2019-2024)

Table 15. Global Gastric Antisecretory Drug Sales Market Share by Region (2025-2030)

Table 16. Global Gastric Antisecretory Drug Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global Gastric Antisecretory Drug Sales Share by Manufacturers (2019-2024)

Table 18. Global Gastric Antisecretory Drug Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Gastric Antisecretory Drug Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Gastric Antisecretory Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Gastric Antisecretory Drug Price by Manufacturers 2019-2024 (US$/Unit)

Table 22. Global Gastric Antisecretory Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Gastric Antisecretory Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Antisecretory Drug as of 2023)

Table 24. Global Key Manufacturers of Gastric Antisecretory Drug, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Gastric Antisecretory Drug, Product Offered and Application

Table 26. Global Key Manufacturers of Gastric Antisecretory Drug, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Gastric Antisecretory Drug Sales by Type (2019-2024) & (K Units)

Table 29. Global Gastric Antisecretory Drug Sales by Type (2025-2030) & (K Units)

Table 30. Global Gastric Antisecretory Drug Sales Share by Type (2019-2024)

Table 31. Global Gastric Antisecretory Drug Sales Share by Type (2025-2030)

Table 32. Global Gastric Antisecretory Drug Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Gastric Antisecretory Drug Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Gastric Antisecretory Drug Revenue Share by Type (2019-2024)

Table 35. Global Gastric Antisecretory Drug Revenue Share by Type (2025-2030)

Table 36. Gastric Antisecretory Drug Price by Type (2019-2024) & (US$/Unit)

Table 37. Global Gastric Antisecretory Drug Price Forecast by Type (2025-2030) & (US$/Unit)

Table 38. Global Gastric Antisecretory Drug Sales by Application (2019-2024) & (K Units)

Table 39. Global Gastric Antisecretory Drug Sales by Application (2025-2030) & (K Units)

Table 40. Global Gastric Antisecretory Drug Sales Share by Application (2019-2024)

Table 41. Global Gastric Antisecretory Drug Sales Share by Application (2025-2030)

Table 42. Global Gastric Antisecretory Drug Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Gastric Antisecretory Drug Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Gastric Antisecretory Drug Revenue Share by Application (2019-2024)

Table 45. Global Gastric Antisecretory Drug Revenue Share by Application (2025-2030)

Table 46. Gastric Antisecretory Drug Price by Application (2019-2024) & (US$/Unit)

Table 47. Global Gastric Antisecretory Drug Price Forecast by Application (2025-2030) & (US$/Unit)

Table 48. US & Canada Gastric Antisecretory Drug Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada Gastric Antisecretory Drug Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada Gastric Antisecretory Drug Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Gastric Antisecretory Drug Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Gastric Antisecretory Drug Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada Gastric Antisecretory Drug Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada Gastric Antisecretory Drug Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Gastric Antisecretory Drug Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Gastric Antisecretory Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Gastric Antisecretory Drug Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Gastric Antisecretory Drug Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Gastric Antisecretory Drug Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada Gastric Antisecretory Drug Sales by Country (2025-2030) & (K Units)

Table 61. Europe Gastric Antisecretory Drug Sales by Type (2019-2024) & (K Units)

Table 62. Europe Gastric Antisecretory Drug Sales by Type (2025-2030) & (K Units)

Table 63. Europe Gastric Antisecretory Drug Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Gastric Antisecretory Drug Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Gastric Antisecretory Drug Sales by Application (2019-2024) & (K Units)

Table 66. Europe Gastric Antisecretory Drug Sales by Application (2025-2030) & (K Units)

Table 67. Europe Gastric Antisecretory Drug Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Gastric Antisecretory Drug Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Gastric Antisecretory Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Gastric Antisecretory Drug Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Gastric Antisecretory Drug Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Gastric Antisecretory Drug Sales by Country (2019-2024) & (K Units)

Table 73. Europe Gastric Antisecretory Drug Sales by Country (2025-2030) & (K Units)

Table 74. China Gastric Antisecretory Drug Sales by Type (2019-2024) & (K Units)

Table 75. China Gastric Antisecretory Drug Sales by Type (2025-2030) & (K Units)

Table 76. China Gastric Antisecretory Drug Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Gastric Antisecretory Drug Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Gastric Antisecretory Drug Sales by Application (2019-2024) & (K Units)

Table 79. China Gastric Antisecretory Drug Sales by Application (2025-2030) & (K Units)

Table 80. China Gastric Antisecretory Drug Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Gastric Antisecretory Drug Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Gastric Antisecretory Drug Sales by Type (2019-2024) & (K Units)

Table 83. Asia Gastric Antisecretory Drug Sales by Type (2025-2030) & (K Units)

Table 84. Asia Gastric Antisecretory Drug Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Gastric Antisecretory Drug Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Gastric Antisecretory Drug Sales by Application (2019-2024) & (K Units)

Table 87. Asia Gastric Antisecretory Drug Sales by Application (2025-2030) & (K Units)

Table 88. Asia Gastric Antisecretory Drug Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Gastric Antisecretory Drug Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Gastric Antisecretory Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Gastric Antisecretory Drug Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Gastric Antisecretory Drug Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Gastric Antisecretory Drug Sales by Region (2019-2024) & (K Units)

Table 94. Asia Gastric Antisecretory Drug Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America Gastric Antisecretory Drug Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America Gastric Antisecretory Drug Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Gastric Antisecretory Drug Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America Gastric Antisecretory Drug Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Gastric Antisecretory Drug Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America Gastric Antisecretory Drug Sales by Country (2025-2030) & (K Units)

Table 108. Bayer Company Information

Table 109. Bayer Description and Major Businesses

Table 110. Bayer Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 111. Bayer Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Bayer Recent Developments

Table 113. Cadila Pharmaceuticals Company Information

Table 114. Cadila Pharmaceuticals Description and Major Businesses

Table 115. Cadila Pharmaceuticals Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 116. Cadila Pharmaceuticals Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Cadila Pharmaceuticals Recent Developments

Table 118. AstraZeneca Company Information

Table 119. AstraZeneca Description and Major Businesses

Table 120. AstraZeneca Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 121. AstraZeneca Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. AstraZeneca Recent Developments

Table 123. Jiangsu Aosaikang Company Information

Table 124. Jiangsu Aosaikang Description and Major Businesses

Table 125. Jiangsu Aosaikang Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 126. Jiangsu Aosaikang Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Jiangsu Aosaikang Recent Developments

Table 128. Eisai Company Information

Table 129. Eisai Description and Major Businesses

Table 130. Eisai Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 131. Eisai Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Eisai Recent Developments

Table 133. Pfizer Company Information

Table 134. Pfizer Description and Major Businesses

Table 135. Pfizer Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 136. Pfizer Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Pfizer Recent Developments

Table 138. Altana Pharma Company Information

Table 139. Altana Pharma Description and Major Businesses

Table 140. Altana Pharma Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 141. Altana Pharma Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Altana Pharma Recent Developments

Table 143. Takeda Company Information

Table 144. Takeda Description and Major Businesses

Table 145. Takeda Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 146. Takeda Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Takeda Recent Developments

Table 148. NCPC Company Information

Table 149. NCPC Description and Major Businesses

Table 150. NCPC Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 151. NCPC Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. NCPC Recent Developments

Table 153. Luoxin Company Information

Table 154. Luoxin Description and Major Businesses

Table 155. Luoxin Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 156. Luoxin Gastric Antisecretory Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Luoxin Recent Developments

Table 158. Key Raw Materials Lists

Table 159. Raw Materials Key Suppliers Lists

Table 160. Gastric Antisecretory Drug Distributors List

Table 161. Gastric Antisecretory Drug Customers List

Table 162. Gastric Antisecretory Drug Market Trends

Table 163. Gastric Antisecretory Drug Market Drivers

Table 164. Gastric Antisecretory Drug Market Challenges

Table 165. Gastric Antisecretory Drug Market Restraints

Table 166. Research Programs/Design for This Report

Table 167. Key Data Information from Secondary Sources

Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. Gastric Antisecretory Drug Product Picture

Figure 2. Global Gastric Antisecretory Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Gastric Antisecretory Drug Market Share by Type in 2023 & 2030

Figure 4. H2-receptor Antagonists Product Picture

Figure 5. Gastric Proton Pump Inhibitors Product Picture

Figure 6. Others Product Picture

Figure 7. Global Gastric Antisecretory Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Gastric Antisecretory Drug Market Share by Application in 2023 & 2030

Figure 9. Dyspepsia

Figure 10. Peptic Ulcer

Figure 11. Gastroesophageal Reflux

Figure 12. Others

Figure 13. Gastric Antisecretory Drug Report Years Considered

Figure 14. Global Gastric Antisecretory Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Gastric Antisecretory Drug Revenue 2019-2030 (US$ Million)

Figure 16. Global Gastric Antisecretory Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 17. Global Gastric Antisecretory Drug Revenue Market Share by Region (2019-2030)

Figure 18. Global Gastric Antisecretory Drug Sales 2019-2030 ((K Units)

Figure 19. Global Gastric Antisecretory Drug Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Gastric Antisecretory Drug Sales YoY (2019-2030) & (K Units)

Figure 21. US & Canada Gastric Antisecretory Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Gastric Antisecretory Drug Sales YoY (2019-2030) & (K Units)

Figure 23. Europe Gastric Antisecretory Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Gastric Antisecretory Drug Sales YoY (2019-2030) & (K Units)

Figure 25. China Gastric Antisecretory Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Gastric Antisecretory Drug Sales YoY (2019-2030) & (K Units)

Figure 27. Asia (excluding China) Gastric Antisecretory Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Gastric Antisecretory Drug Sales YoY (2019-2030) & (K Units)

Figure 29. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 30. The Gastric Antisecretory Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 31. The Top 5 and 10 Largest Manufacturers of Gastric Antisecretory Drug in the World: Market Share by Gastric Antisecretory Drug Revenue in 2023

Figure 32. Global Gastric Antisecretory Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 33. Global Gastric Antisecretory Drug Sales Market Share by Type (2019-2030)

Figure 34. Global Gastric Antisecretory Drug Revenue Market Share by Type (2019-2030)

Figure 35. Global Gastric Antisecretory Drug Sales Market Share by Application (2019-2030)

Figure 36. Global Gastric Antisecretory Drug Revenue Market Share by Application (2019-2030)

Figure 37. US & Canada Gastric Antisecretory Drug Sales Market Share by Type (2019-2030)

Figure 38. US & Canada Gastric Antisecretory Drug Revenue Market Share by Type (2019-2030)

Figure 39. US & Canada Gastric Antisecretory Drug Sales Market Share by Application (2019-2030)

Figure 40. US & Canada Gastric Antisecretory Drug Revenue Market Share by Application (2019-2030)

Figure 41. US & Canada Gastric Antisecretory Drug Revenue Share by Country (2019-2030)

Figure 42. US & Canada Gastric Antisecretory Drug Sales Share by Country (2019-2030)

Figure 43. U.S. Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 44. Canada Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 45. Europe Gastric Antisecretory Drug Sales Market Share by Type (2019-2030)

Figure 46. Europe Gastric Antisecretory Drug Revenue Market Share by Type (2019-2030)

Figure 47. Europe Gastric Antisecretory Drug Sales Market Share by Application (2019-2030)

Figure 48. Europe Gastric Antisecretory Drug Revenue Market Share by Application (2019-2030)

Figure 49. Europe Gastric Antisecretory Drug Revenue Share by Country (2019-2030)

Figure 50. Europe Gastric Antisecretory Drug Sales Share by Country (2019-2030)

Figure 51. Germany Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 52. France Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 53. U.K. Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 54. Italy Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 55. Russia Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 56. China Gastric Antisecretory Drug Sales Market Share by Type (2019-2030)

Figure 57. China Gastric Antisecretory Drug Revenue Market Share by Type (2019-2030)

Figure 58. China Gastric Antisecretory Drug Sales Market Share by Application (2019-2030)

Figure 59. China Gastric Antisecretory Drug Revenue Market Share by Application (2019-2030)

Figure 60. Asia Gastric Antisecretory Drug Sales Market Share by Type (2019-2030)

Figure 61. Asia Gastric Antisecretory Drug Revenue Market Share by Type (2019-2030)

Figure 62. Asia Gastric Antisecretory Drug Sales Market Share by Application (2019-2030)

Figure 63. Asia Gastric Antisecretory Drug Revenue Market Share by Application (2019-2030)

Figure 64. Asia Gastric Antisecretory Drug Revenue Share by Region (2019-2030)

Figure 65. Asia Gastric Antisecretory Drug Sales Share by Region (2019-2030)

Figure 66. Japan Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 67. South Korea Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 68. China Taiwan Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 69. Southeast Asia Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 70. India Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 71. Middle East, Africa and Latin America Gastric Antisecretory Drug Sales Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Gastric Antisecretory Drug Sales Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Gastric Antisecretory Drug Revenue Share by Country (2019-2030)

Figure 76. Middle East, Africa and Latin America Gastric Antisecretory Drug Sales Share by Country (2019-2030)

Figure 77. Brazil Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 78. Mexico Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 79. Turkey Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 80. Israel Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 81. GCC Countries Gastric Antisecretory Drug Revenue (2019-2030) & (US$ Million)

Figure 82. Gastric Antisecretory Drug Value Chain

Figure 83. Gastric Antisecretory Drug Production Process

Figure 84. Channels of Distribution

Figure 85. Distributors Profiles

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Proton Pump Inhibitor Drug Market Research Report 2025

Global Gastric Lavage Market Insights Forecast to 2030

Gastroesophageal Reflux Drugs Market

Gastric Motility Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Peptic Ulcer Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Antiulcer Agents and Acid Suppressants Market Research Report 2024

Acute Gastritis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stomach Peptic Ulcer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptic Ulcer Treatment Drugs Market Research Report 2024

Gastric Carcinomas Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Gastritis Drugs Market Research Report 2024

Global Gastric Inhibitory Polypeptide Receptor Market Research Report 2024

Global Acid Suppressant Market Research Report 2024

Global H2 Receptor Antagonists Market Insights Forecast to 2030

Gastric Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptic Ulcer Relief Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gastroesophageal Reflux Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastric Electrical Stimulators Market Insights Forecast to 2030

Global Gastric Mucosal Protective Agent Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions